var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('5/1 - 8:34 AM \; \; | \n'); } if (allow) { document.write('Genprex to Present and Participate at Upcoming May Investor and Industry Conferences | \n'); } if (allow) { document.write('
4/9 - 8:34 AM \; \; | \n'); } if (allow) { document.write('Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa®\; and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex®\; Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting | \n'); } if (allow) { document.write('
4/3 - 8:33 AM \; \; | \n'); } if (allow) { document.write('Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa®\; Therapy in Combination with Tecentriq®\; to Treat Small Cell Lung Cancer | \n'); } if (allow) { document.write('
4/2 - 8:34 AM \; \; | \n'); } if (allow) { document.write('Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex®\; Delivery System | \n'); } if (allow) { document.write('
3/22 - 4:11 PM \; \; | \n'); } if (allow) { document.write('Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | \n'); } if (allow) { document.write('
3/19 - 1:26 PM \; \; | \n'); } if (allow) { document.write('Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | \n'); } if (allow) { document.write('
3/19 - 8:38 AM \; \; | \n'); } if (allow) { document.write('Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | \n'); } if (allow) { document.write('
3/12 - 9:06 AM \; \; | \n'); } if (allow) { document.write('Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa®\; Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers | \n'); } if (allow) { document.write('
3/6 - 8:31 AM \; \; | \n'); } if (allow) { document.write('Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa®\; and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex®\; Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting | \n'); } if (allow) { document.write('
2/7 - 8:16 AM \; \; | \n'); } if (allow) { document.write('Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators | \n'); } if (allow) { document.write('
2/6 - 7:31 AM \; \; | \n'); } if (allow) { document.write('Genprex to Present at Upcoming BIO CEO & Investor Conference | \n'); } if (allow) { document.write('
2/5 - 7:31 AM \; \; | \n'); } if (allow) { document.write('Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa®\; Therapy in Combination with Tagrisso®\; to Treat Non-Small Cell Lung Cancer | \n'); } if (allow) { document.write('
1/31 - 8:43 AM \; \; | \n'); } if (allow) { document.write('Genprex Announces 1-for-40 Reverse Stock Split Effective February 2, 2024 | \n'); } if (allow) { document.write('
1/5 - 7:01 AM \; \; | \n'); } if (allow) { document.write('Genprex Provides Business Update and Outlook for 2024 | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' |